A randomized pilot trial on the effect of granulocyte-colony stimulating factor on antibody response in hemodialysis patients who had not responded to routine hepatitis B virus vaccine

Background: Various strategies have been applied to improve the response to hepatitis B virus (HBV) vaccination in hemodialysis patients. Objectives: The present study was under taken to compare the seroconversion rate of hemodialysis patients who had not respond to 3 intramuscular (IM) doses (40 μg...

Descripción completa

Detalles Bibliográficos
Autores principales: Roozbeh, Jamshid, Bagheri-Lankarani, Kamran, Mohaghegh, Poopak, Raeesjalali, Ghanbarali, Behzadi, Saeed, Sagheb, Mehdi, Vossoughi, Mehrdad, Bastani, Bahar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Diabetic Nephropathy Prevention 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316580/
https://www.ncbi.nlm.nih.gov/pubmed/25657980
http://dx.doi.org/10.12860/jnp.2015.03

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316580/
https://www.ncbi.nlm.nih.gov/pubmed/25657980
http://dx.doi.org/10.12860/jnp.2015.03

Ejemplares similares